Literature DB >> 18996177

Antiangiogenic activity of Tripterygium wilfordii and its terpenoids.

Ming-Fang He1, Lin Liu, Wei Ge, Pang-Chui Shaw, Renwang Jiang, Li-Wha Wu, Paul Pui-Hay But.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Tripterygium wilfordii Hook. f. (Celastraceae) has been traditionally used as folk medicine for centuries in China for the treatment of immune-inflammatory diseases. AIM OF THE STUDY: This study aimed to assess the antiangiogenic activities which support the therapeutic use of Tripterygium wilfordii and its terpenoids for angiogenesis disease such as cancer.
MATERIALS AND METHODS: The ethanol extract of Tripterygium wilfordii and subsequent fractions were evaluated on an in vivo antiangiogenic zebrafish embryo model.
RESULTS: Three antiangiogenic terpenoids were isolated by bioassay-guided purification, namely, celastrol (4), cangoronine (5) and triptolide (7). Among them, triptolide manifested the most potent antiangiogenic activity against vessel formation by nearly 50% at 1.2 microM. Semi-quantitative RT-PCR analysis revealed that triptolide dose- and time-dependently reduced the mRNA expression of angiopoietin (angpt)2 and tie2 in zebrafish, indicating the involvement of angpt2/tie2 signaling pathway in the antiangiogenic action of triptolide.
CONCLUSIONS: The discovery of an alternative pathway further confirms the value of ethnopharmacological investigations into traditional botanicals for leads for potential drug development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18996177     DOI: 10.1016/j.jep.2008.09.033

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  16 in total

1.  Triptolide and management of systemic malignancies besides pancreatic carcinomas.

Authors:  Shailendra Kapoor
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

2.  Celastrol regulates multiple nuclear transcription factors belonging to HSP90's clients in a dose- and cell type-dependent way.

Authors:  Denghai Zhang; Limin Xu; Fanfan Cao; Tingxuan Wei; Chunxin Yang; Georges Uzan; Bin Peng
Journal:  Cell Stress Chaperones       Date:  2010-05-18       Impact factor: 3.667

3.  Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors.

Authors:  Bokyung Sung; Byoungduck Park; Vivek R Yadav; Bharat B Aggarwal
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

Review 4.  Mushrooms: an emerging resource for therapeutic terpenoids.

Authors:  Adhiraj Dasgupta; Krishnendu Acharya
Journal:  3 Biotech       Date:  2019-09-24       Impact factor: 2.406

5.  Evaluation of pyridoacridine alkaloids in a zebrafish phenotypic assay.

Authors:  Xiaomei Wei; Tim S Bugni; Mary Kay Harper; Imelda T Sandoval; Elizabeth J Manos; Jennifer Swift; Ryan M Van Wagoner; David A Jones; Chris M Ireland
Journal:  Mar Drugs       Date:  2010-06-02       Impact factor: 5.118

6.  Zebrafish bioassay-guided natural product discovery: isolation of angiogenesis inhibitors from East African medicinal plants.

Authors:  Alexander D Crawford; Sandra Liekens; Appolinary R Kamuhabwa; Jan Maes; Sebastian Munck; Roger Busson; Jef Rozenski; Camila V Esguerra; Peter A M de Witte
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

7.  Anti-cancer natural products isolated from chinese medicinal herbs.

Authors:  Wen Tan; Jinjian Lu; Mingqing Huang; Yingbo Li; Meiwan Chen; Guosheng Wu; Jian Gong; Zhangfeng Zhong; Zengtao Xu; Yuanye Dang; Jiajie Guo; Xiuping Chen; Yitao Wang
Journal:  Chin Med       Date:  2011-07-22       Impact factor: 5.455

8.  Formulation, characterization, and evaluation of in vitro skin permeation and in vivo pharmacodynamics of surface-charged tripterine-loaded nanostructured lipid carriers.

Authors:  Yan Chen; Lei Zhou; Ling Yuan; Zhen-hai Zhang; Xuan Liu; Qingqing Wu
Journal:  Int J Nanomedicine       Date:  2012-06-19

9.  Phytochemicals attenuating aberrant activation of β-catenin in cancer cells.

Authors:  Dan Wang; Mitchell L Wise; Feng Li; Moul Dey
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

10.  Triptolide Transcriptionally Represses HER2 in Ovarian Cancer Cells by Targeting NF-κB.

Authors:  Chien-Chih Ou; Yuan-Wu Chen; Shih-Chung Hsu; Huey-Kang Sytwu; Shih-Hurng Loh; Jhy-Wei Li; Jah-Yao Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-12-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.